Log In

 
Company : GVK BIO 
Friday, December 2, 2016 9:00AM IST (3:30AM GMT)
 
GVK BIO Announces Launch of a GMP Compliant Analytical Services Laboratory
Capabilities developed to offer Development & Validation of research methods & compendial testing of API, finished products & raw materials to life sciences industry globally
 
Hyderabad, India

GVK Biosciences, one of Asia’s leading life sciences service organizations today announced the launch of an Analytical Services Laboratory in Hyderabad, India. The dedicated GMP compliant facility is managed by validated Laboratory Information Management Systems (LIMS). It is compliant with the highest quality standards required by regulatory bodies and clients for the development and marketing of medicinal products.
 
GVK BIO can now offer its clients, development and validation of research methods and compendial testing of API, finished products and raw materials. The analytical services expertise span across:
 

  • Analytical method development, validations & optimization
  • Identification and isolation of trace level impurities
  • Method development & quantification of genotoxic impurities and heavy metals
  • Isolation of impurities by Prep LC & SFC
  • Characterization of polymorphs/pseudo polymorphs
  • Stability studies for drug product and drug substance as per ICH guidelines
  • Dissolution profile
  • Extractable & leachable study & quantification
  • Particle size distribution analysis 
     
Dr. Sudhir Kumar Singh, President - Discovery and Development Services, GVK BIO said, “Global Pharma is looking at one-stop solutions and much of the cGMP testing is outsourced. Integrated Analytical Services is a strategic fit for GVK BIO and lets our customers focus on their core area of R&D and Manufacturing. We have invested in best-in-class equipment and experienced talent pool enabling us to extend a broad range of consultative high quality Analytical testing services that comply with global regulatory requirements.”
 
About GVK BIO

GVK Biosciences (GVK BIO) is one of Asia’s leading life-sciences services organization providing a broad spectrum of services across the R&D and manufacturing value chain with a focus on speed and quality. GVK BIO’s capabilities include Integrated Drug discovery, Chemistry, Biology, Large molecule R&D, Chemical Development, Formulation & Analytical development, Contract Manufacturing and Drug Repurposing.
                   
GVK BIO’s diverse portfolio of more than 400 customers include the world’s top 10 corporations in the field of Pharmaceuticals, Biotechnology and Agrochemicals along with leading Academic institutions. Please visit us at www.gvkbio.com to learn more.

 
For News Release background on GVK BIO click here
 
Media Contact Details
Shankar Chelluri, Director – Corporate Communications, GVK BIO, +91 (40) 66921822, shankar.chelluri@gvkbio.com
 
 
Submit your press release
More News from GVK BIO

14/11/2017 5:00PM Image

GVK BIO Completes 10 Year Collaboration with Nuevolution

GVK BIO, a leading Contract Research & Development (R&D) Organization that services the global Biopharma industry, known for its customer focus, today celebrated 10 years of research and development collaboration with ...

Similar News

26/04/2018 7:55PM

Bentley Systems Acquires Plaxis, and Complementary SoilVision, to Integrate Geotechnical Engineering within Digital Workflows for Infrastructure Projects

Bentley Systems, Incorporated, a leading global provider of comprehensive software solutions for advancing infrastructure, today announced the acquisition of Plaxis, the leading provider of geotechnical software, based ...

No Image

26/04/2018 7:40PM

Gemalto Enables Digitization of Hong Kong’s Octopus Card into Samsung Pay

Gemalto, the world leader in digital security, announced that its Trusted Service Hub (TSH) is enabling the secure digitization of Octopus contactless smart cards into Samsung Pay. Named Smart Octopus in Samsung Pay, ...